Categories
Anticancer Drugs Enasidenib Oncology Pharmacology Physiotherapy

Enasidenib and Differentiation Syndrome

In this article we will discuss Enasidenib and Differentiation Syndrome

In this article, we will discuss Enasidenib and Differentiation Syndrome. So, let’s get started.

Differentiation Syndrome

Advise patients on the risks of developing differentiation syndrome as early as 10 days and during the first 5 months on treatment. Ask patients to immediately report any symptoms suggestive of differentiation syndrome, such as fever, cough or difficulty breathing, bone pain, rapid weight gain or
swelling of their arms or legs, to their healthcare provider for further evaluation

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.